Loren Stefan's Form 4/A amendment
AmendedCellectar Biosciences, Inc. (CLRB) · filed Jul 10, 2026
- Accession no.
- 0001104659-26-082761
- Filed
- Jul 10, 2026, 9:00 PM ET
- Trade date
- Jul 8, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jul 8, 2026
This filing lists 1 derivative transaction. It was filed 2 days after the trade.
This amendment replaces 0001104659-26-082009 (filed Jul 8, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Loren StefanCIK 0001441500 | Other: Consultant |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | Common stock | AGrant or awardAcquired | +15,000 | $0.00 | $0 | 15,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This option shall vest in full on July 8, 2027, subject to the reporting person's continued service through the applicable vesting date.
Remarks
This Form 4 amendment is being filed solely to correct the exercise price of the stock option that was reported in the original Form 4 filed by the reporting person on July 8, 2026.